Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Cancer Res. 2020 Feb 3;80(7):1428–1437. doi: 10.1158/0008-5472.CAN-19-1394

Table 1.

In silico analysis of publicly available VCaP transcription factor ChIP-Seq data sets demonstrating significant fold-enrichment for ERG binding in the region of the transcription start site for IRS2. Data analysis performed using ChIP-Atlas.

Experiment ID Antigen Cell Line No. Peaks Overlaps/Control Log p-value Fold Enrichment
SRX1629251 ERG VCaP 963 212/18438 −1.9 86.97
SRX471871 BRD3 VCaP 1883 232/18438 −1.9 79.47
SRX1629253 ERG VCaP 756 307/18438 −1.8 60.06
SRX1490930 RB1 VCaP 499 334/18438 −1.7 55.2
SRX595673 FOXP1 VCaP 8264 755/18438 −1.4 24.42
SRX2642375 HOXB13 VCaP 9544 758/18438 −1.4 24.32